Dr. Himabindu M. Lanka, MD

Dr. Lanka practices at ChristianaCare Adult Outpatient Psychiatry & Therapy in Newark, Delaware.

Dr. Lanka's NPI, 1780964825, was assigned on August 21, 2011. Dr. Lanka holds New Jersey license 25MA10180800.

Dr. Lanka's primary practice is ChristianaCare Adult Outpatient Psychiatry & Therapy, at 4755 Ogletown Stanton Road, Newark, DE 19713. The practice phone is (302) 320-2926.

Dr. Lanka's primary practice is ChristianaCare Adult Outpatient Psychiatry & Therapy in Newark, Delaware. Dr. Lanka is also affiliated with Christiana Hospital. The medical group on file is ChristianaCare. Dmand AI also links Dr. Lanka to 2 more hospitals, 3 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lanka practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Lanka's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Lanka's licenses on file in 3 states: New Jersey, Delaware and Pennsylvania.

CMS data shows 608 Medicare services from Dr. Lanka across 6 procedure codes in 2024, for 267 Medicare patients. Medicare paid $50,212 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 267 Medicare patients who saw Dr. Lanka in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lanka's median patient age at 72, with 52% women.

In 2024, Dr. Lanka wrote 236 Medicare Part D claims for 123 patients. 89% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $157 in total drug cost. In 2022, CMS named 108 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lanka for performance year 2024, reported through an alternative payment model (APM). Dr. Lanka accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Dr. Lanka from 5 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $68.